Skip to main content
Top
Gepubliceerd in: Quality of Life Research 2/2009

01-03-2009 | Brief Communication

Estimating health utilities in patients with asthma and COPD: evidence on the performance of EQ-5D and SF-6D

Auteurs: A. Szende, N. K. Leidy, E. Ståhl, K. Svensson

Gepubliceerd in: Quality of Life Research | Uitgave 2/2009

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Objective

The objective of this study was to understand systematic differences in utility values derived from the EQ-5D and the SF-6D in two respiratory populations with heterogeneous disease severity.

Methods

This study involved secondary analysis of data from two cross-sectional surveys of patients with asthma (N = 228; Hungary) and COPD (N = 176; Sweden). Disease severity was defined according to GINA and GOLD guidelines for asthma and COPD, respectively. EQ-5D and SF-6D scores and their distributional characteristics were compared across the two samples by disease severity level.

Results

Within each patient population, mean EQ-5D and SF-6D scores were similar for the overall group and for those with moderate disease. Mean scores varied for patients with mild and severe disease. EQ-5D versus SF-6D scores in the asthma group by severity levels were 0.89 versus 0.80, 0.70 versus 0.73, 0.63 versus 0.64, and 0.51 versus 0.63, respectively. EQ-5D versus SF-6D scores in the COPD group by severity levels were 0.85 versus 0.80, 0.73 versus 0.73, 0.74 versus 0.73, and 0.53 versus 0.62, respectively.

Conclusions

Results suggest the EQ-5D and SF-6D do not yield consistent utility values in patients with asthma and COPD due to differences in underlying valuation techniques and the EQ-5D’s limited response options relative to mild disease.
Literatuur
6.
7.
go back to reference Global initiative for asthma (GINA) guidelines. (1998). Global Strategy for Asthma Management and Prevention NHLBI/WHO Workshop Report. Global initiative for asthma (GINA) guidelines. (1998). Global Strategy for Asthma Management and Prevention NHLBI/WHO Workshop Report.
8.
go back to reference Ståhl, E., Lindberg, A., Rönmark, E., Svensson, K., Jansson, S.-A., Andersson, F., et al. (2001). The level of health-related quality of life in patients with COPD and its dependence on age, gender, and disease severity. The European Respiratory Journal, 18(Suppl 33), 184s. doi:10.1183/09031936.01.00084401. Ståhl, E., Lindberg, A., Rönmark, E., Svensson, K., Jansson, S.-A., Andersson, F., et al. (2001). The level of health-related quality of life in patients with COPD and its dependence on age, gender, and disease severity. The European Respiratory Journal, 18(Suppl 33), 184s. doi:10.​1183/​09031936.​01.​00084401.
9.
go back to reference Pauwels, R. A., Buist, A. S., Calverley, P. M., Jenkins, C. R., Hurd, S. S., & The GOLD Scientific Committee. (2001). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. American Journal of Respiratory and Critical Care Medicine, 163(5), 1047–1048. Pauwels, R. A., Buist, A. S., Calverley, P. M., Jenkins, C. R., Hurd, S. S., & The GOLD Scientific Committee. (2001). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. American Journal of Respiratory and Critical Care Medicine, 163(5), 1047–1048.
10.
go back to reference Szende, A., Oppe, M., & Devlin, N. (Eds.), (2007). The European VAS value set. In EQ–5D value sets. Inventory, comparative review and user guide (pp. 83–85). Dordrecht: Springer. Szende, A., Oppe, M., & Devlin, N. (Eds.), (2007). The European VAS value set. In EQ–5D value sets. Inventory, comparative review and user guide (pp. 83–85). Dordrecht: Springer.
15.
17.
go back to reference Konig, H. H., Ulshofer, A., Gregor, M., von Tirpitz, C., Reinshagen, M., Adler, G., et al. (2002). Validation of the EuroQol questionnaire in patients with inflammatory bowel disease. European Journal of Gastroenterology and Hepatology, 14(11), 1205–1215. doi:10.1097/00042737-200211000-00008.PubMedCrossRef Konig, H. H., Ulshofer, A., Gregor, M., von Tirpitz, C., Reinshagen, M., Adler, G., et al. (2002). Validation of the EuroQol questionnaire in patients with inflammatory bowel disease. European Journal of Gastroenterology and Hepatology, 14(11), 1205–1215. doi:10.​1097/​00042737-200211000-00008.PubMedCrossRef
18.
go back to reference Wu, A. W., Jacobson, K. L., Frick, K. D., Clark, R., Revicki, D. A., Freedberg, K. A., et al. (2002). Validity and responsiveness of the EuroQol as a measure of health-related quality of life in people enrolled in an AIDS clinical trial. Quality of Life Research, 11(3), 273–282. doi:10.1023/A:1015240103565.PubMedCrossRef Wu, A. W., Jacobson, K. L., Frick, K. D., Clark, R., Revicki, D. A., Freedberg, K. A., et al. (2002). Validity and responsiveness of the EuroQol as a measure of health-related quality of life in people enrolled in an AIDS clinical trial. Quality of Life Research, 11(3), 273–282. doi:10.​1023/​A:​1015240103565.PubMedCrossRef
20.
21.
go back to reference Sach, T. H., Barton, G. R., Doherty, M., Muir, K. R., Jenkinson, C., & Avery, A. J. (2007). The relationship between body mass index and health-related quality of life: Comparing the EQ-5D, EuroQol VAS and SF-6D. International Journal of Obesity (London), 31(1), 189–196. doi:10.1038/sj.ijo.0803365.CrossRef Sach, T. H., Barton, G. R., Doherty, M., Muir, K. R., Jenkinson, C., & Avery, A. J. (2007). The relationship between body mass index and health-related quality of life: Comparing the EQ-5D, EuroQol VAS and SF-6D. International Journal of Obesity (London), 31(1), 189–196. doi:10.​1038/​sj.​ijo.​0803365.CrossRef
22.
go back to reference Barton, G. R., Sach, T. H., Doherty, M., Avery, A.J., Jenkinson, C., & Muir K. R. (2007). An assessment of the discriminative ability of the EQ-5D (index), SF-6D, and EQ VAS, using sociodemographic factors and clinical conditions. The European Journal of Health Economics Jun 29 [Epub ahead of print]. Barton, G. R., Sach, T. H., Doherty, M., Avery, A.J., Jenkinson, C., & Muir K. R. (2007). An assessment of the discriminative ability of the EQ-5D (index), SF-6D, and EQ VAS, using sociodemographic factors and clinical conditions. The European Journal of Health Economics Jun 29 [Epub ahead of print].
23.
go back to reference Franks, P., Hanmer, J., & Fryback, D. G. (2006). Relative disutilities of 47 risk factors and conditions assessed with seven preference-based health status measures in a national U.S. sample toward consistency in cost-effectiveness analyses. Medical Care, 44(5), 478–485. doi:10.1097/01.mlr.0000207464.61661.05.PubMedCrossRef Franks, P., Hanmer, J., & Fryback, D. G. (2006). Relative disutilities of 47 risk factors and conditions assessed with seven preference-based health status measures in a national U.S. sample toward consistency in cost-effectiveness analyses. Medical Care, 44(5), 478–485. doi:10.​1097/​01.​mlr.​0000207464.​61661.​05.PubMedCrossRef
25.
go back to reference Boonen, A., van der Heijde, D., Landewe, R., van Tubergen, A., Mielants, H., Dougados, M., et al. (2007). How do the EQ-5D, SF-6D and the well-being rating scale compare in patients with ankylosing spondylitis? Annals of the Rheumatic Diseases, 66(6), 771–777. doi:10.1136/ard.2006.060384.PubMedCrossRef Boonen, A., van der Heijde, D., Landewe, R., van Tubergen, A., Mielants, H., Dougados, M., et al. (2007). How do the EQ-5D, SF-6D and the well-being rating scale compare in patients with ankylosing spondylitis? Annals of the Rheumatic Diseases, 66(6), 771–777. doi:10.​1136/​ard.​2006.​060384.PubMedCrossRef
28.
go back to reference Lamers, L. M., Bouwmans, C. A., van Straten, A., Donker, M. C., & Hakkaart, L. (2006). Comparison of EQ-5D and SF-6D utilities in mental health patients. Health Economics, 15(11), 1229–1236. doi:10.1002/hec.1125.PubMedCrossRef Lamers, L. M., Bouwmans, C. A., van Straten, A., Donker, M. C., & Hakkaart, L. (2006). Comparison of EQ-5D and SF-6D utilities in mental health patients. Health Economics, 15(11), 1229–1236. doi:10.​1002/​hec.​1125.PubMedCrossRef
29.
33.
go back to reference Grieve, R., Grishchenko, M., & Cairns, J. (2008). SF-6D versus EQ-5D: reasons for differences in utility scores and impact on reported cost-utility. The European Journal of Health Economics. (Epub ahead of print). Grieve, R., Grishchenko, M., & Cairns, J. (2008). SF-6D versus EQ-5D: reasons for differences in utility scores and impact on reported cost-utility. The European Journal of Health Economics. (Epub ahead of print).
Metagegevens
Titel
Estimating health utilities in patients with asthma and COPD: evidence on the performance of EQ-5D and SF-6D
Auteurs
A. Szende
N. K. Leidy
E. Ståhl
K. Svensson
Publicatiedatum
01-03-2009
Uitgeverij
Springer Netherlands
Gepubliceerd in
Quality of Life Research / Uitgave 2/2009
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-008-9429-z

Andere artikelen Uitgave 2/2009

Quality of Life Research 2/2009 Naar de uitgave